Is this you? Create Your Porfile
Avatar

Franck Morschhauser

National Health Service

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Franck Morschhauser is active.

Explore More

Publication

Featured researches published by Franck Morschhauser.

Blood | 2007

Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation

Franck Morschhauser; Timothy M. Illidge; Damien Huglo; Giovanni Martinelli; Giovanni Paganelli; Pier Luigi Zinzani; Simon Rule; Anna Marina Liberati; Noel Milpied; Georg Hess; Harald Stein; Joachim Kalmus; Robert Marcus

Blood | 2004

Yttrium-90 Ibritumomab Tiuxetan (Zevalin) for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Appropriate for Autologous Stem Cell Transplantation: Results of an Open-Label Phase II Trial.

Franck Morschhauser; Damien Huglo; Giovanni Martinelli; Giovanni Paganelli; Pier Luigi Zinzani; D. Hadjiyiannakis; Anna Marina Liberati; Tim Illidge; Noel Milpied; Harald Stein; J. Kalmus; P. Morel; U. Reimann; Robert Marcus

Annals of Oncology | 2005

Yttrium-90 ibritumomab tiuxetan (zevalin) induces high response rates in previously treated patients with diffuse large B cell lymphoma (DLBCL)

Franck Morschhauser; Damien Huglo; Giovanni Martinelli; Giovanni Paganelli; Pier Luigi Zinzani; D. Hadjiyiannakis; Anna Marina Liberati; Tim Illidge; Noel Milpied; J. Kalmus; P. Morel; U. Reimann; Robert Marcus

Archive | 2013

for the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

Emmanuel Bachy; Roch Houot; Franck Morschhauser; Anne Sonet; Pauline Brice; Karim Belhadj; G. Cartron; Bruno Audhuy; Christophe Fermé; Pierre Feugier; C. Sebban; Vincent Delwail; Steven Le Gouill; Sophie Lefort; Nicole Brousse; Charles Foussard; Gilles Salles; Chu de Montpellier; Chu de Nancy; Chu de Poitiers; Chu de Nantes

Archive | 2017

EFFICACY AND SAFETY OF RITUXIMAB IN B-CELL POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: RESULTS OF A PROSPECTIVE MULTICENTRE PHASE II STUDY Running head: Rituximab in PTLD

Sylvain Choquet; Veronique Leblond; Raoul Herbrecht; Gerard Socie; Anne-Marie Stoppa; Peter Vandenberghe; Alain Fischer; Franck Morschhauser; Gilles Salles; Walter Feremans; Etienne Vilmer; Marie-Noelle Peraldi; Philippe Lang; Yvon Lebranchu; Eric Oksenhendler; Jeanne Luce Garnier; Thierry Lamy; Arnaud Jaccard; Augustin Ferrant; Fritz Offner; Olivier Hermine; Anne Moreau; Samira Fafi-Kremer; Patrice Morand; Lucienne Chatenoud; Nathalie Berriot-Varoqueaux; Loïc Bergougnoux; Brussels Belgium

Archive | 2016

19. Translating science into therapy of lymphoma

Loic Ysebaert; Roch Houot; Franck Morschhauser

21st European Haematology Association Annual Meeting | 2016

PHASE 2A STUDY OF THE PHOSPHATIDYLINOSITOL-3-KINASE (PI3K) INHIBITOR COPANLISIB IN PATIENTS WITH RELAPSED/REFRACTORY, INDOLENT OR AGGRESSIVE LYMPHOMA. P318, 2016: Non-Hodgkin & Hodgkin lymphoma - Novel agents

Martin Dreyling; Franck Morschhauser; Krimo Bouabdallah; David Cunningham; Dominique Bron; Kim Linton; Sarit Assouline; Gregor Verhoef; Catherine Thieblemont; Umberto Vitolo; J. Garcia-Vargas; Igor Gorbatchevsky; Manoel Neves; Julia Grunert; Florian Hiemeyer; Barrett H. Childs; Pier Luigi Zinzani

Hématologie | 2014

First Lymphoma Study Association workshopsDeauville (France), 10 th -12 th October 2013 – part 2

Julien Rossignol; Clémentine Sarkozy; Gabriel Brisou; Remy Gressin; Catherine Thieblemont; Morgane Cheminant; Tereza Coman; Richard Delarue; Philippe Gaulard; Clémentine Salvado; Elodie Scherman; G. Cartron; Franck Morschhauser

Archive | 2013

lymphoma patients: results of the GELA-GOELAMS FL2000 study Rituximab combined with chemotherapy and interferon in follicular

Charles Foussard; Christophe Fermé; C. Sebban; Luc Xerri; Jean-François Rossi; Corinne Haioun; Pauline Brice; Beatrice Mahe; Réda Bouabdallah; Gilles Salles; N. Mounier; Sophie de Guibert; Franck Morschhauser; Chantal Doyen

Society of Nuclear Medicine Annual Meeting Abstracts | 2012

Metabolic tumor volume, total lesion glycolysis and {Delta}SUVmax analysis in patients with diffuse large B cell lymphoma in the LNH07-3B trial

Myriam Sasanelli; Alina Berriolo-Riedinger; Rene Casasnovas; Franck Morschhauser; Emmanuel Itti; Damien Huglo; Annibale Versari; Julia Chalaye; Michel Meignan; Francesco Scopinaro

Explore More

Collaboration

Dive into the Franck Morschhauser's collaboration.

Top Co-Authors
Avatar

Damien Huglo

university of lille

View shared research outputs
Top Co-Authors
Avatar

Noel Milpied

University of Nantes

View shared research outputs
Top Co-Authors
Avatar

Pier Luigi Zinzani

Sapienza University of Rome

View shared research outputs
Top Co-Authors
Avatar

Gilles Salles

University of Regensburg

View shared research outputs
Top Co-Authors
Avatar

Robert Marcus

University of Cambridge

View shared research outputs
Top Co-Authors
Avatar

Anna Marina Liberati

University of Perugia

View shared research outputs
Top Co-Authors
Avatar

Giovanni Martinelli

University of Bologna

View shared research outputs
Top Co-Authors
Avatar

Giovanni Paganelli

European Institute of Oncology

View shared research outputs
Top Co-Authors
Avatar

Tim Illidge

University of Manchester

View shared research outputs
Top Co-Authors
Avatar

Arnaud Jaccard

University of Limoges

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge